PRECISION BIOSCIENCES INC - Common Stock, $0.000005 par value per share (DTIL)

Q: What does CUSIP 74019P207 represent in this 13F holders report?

CUSIP 74019P207 is the security identifier for DTIL - PRECISION BIOSCIENCES INC - Common Stock, $0.000005 par value per share used to aggregate holder disclosures.

Q: How many institutions held DTIL - PRECISION BIOSCIENCES INC - Common Stock, $0.000005 par value per share in Q4 2025?

67 institutional investors reported DTIL - PRECISION BIOSCIENCES INC - Common Stock, $0.000005 par value per share for Q4 2025. Use the holders table for investor-level position and value details.

CUSIP: 74019P207

Q4 2025 13F Holders as of 31 Dec 2025

Type / Class: Equity / Common Stock, $0.000005 par value per share
Shares outstanding: 25,804,443
Total 13F shares: 15,096,207
Share change: +8,251,010
Total reported value: $62,794,720
Price per share: $4.16
Number of holders: 67
Value change: +$33,303,415
Number of buys: 40
Number of sells: 15

Quarterly Holders Quick Answers

What is CUSIP 74019P207?
CUSIP 74019P207 identifies DTIL - PRECISION BIOSCIENCES INC - Common Stock, $0.000005 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2026
Previous quarter: Q3 2025

Recent filing periods for CUSIP 74019P207:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of DTIL - PRECISION BIOSCIENCES INC - Common Stock, $0.000005 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Octagon Capital Advisors LP	13D/G	—	10%	2,328,485	$9,570,073	$0	31 Dec 2025	13D/G
Aberdeen Group plc	13D/G	—	8.9%	2,138,603	$8,896,588	$0	31 Dec 2025	13D/G
Bleichroeder LP	13D/G 13F	Company	8.2%	1,900,000	$7,809,000	+$3,390,750	31 Dec 2025	13D/G 13F
Lynx1 Capital Management LP	13F 13D/G	Company	4.1% from 13D/G	1,042,596	$5,755,130	—	30 Sep 2025	13F 13D/G
Readout Capital, LP	13D/G	Matthew Smith	9.4%	1,119,311	$4,980,934	+$829,645	30 Jun 2025	13D/G
NOVARTIS PHARMA AG	3/4/5 13D/G	10%+ Owner	3.7% from 13D/G	12,407,440	$4,590,753	—	15 Jun 2022	3/4/5 13D/G
TANG CAPITAL MANAGEMENT LLC	13F	Company	2.5%	653,649	$3,608,142	—	30 Sep 2025	13F
VANGUARD GROUP INC	13F	Company	1.9%	492,596	$2,719,130	—	30 Sep 2025	13F
HIGHBRIDGE CAPITAL MANAGEMENT LLC	13D/G	—	3.7%	406,250	$2,165,312	$0	31 Mar 2025	13D/G
Weinstein Benjamin	13D/G	—	5.2%	395,489	$2,107,956	$0	18 Mar 2025	13D/G
Derek Jantz	3/4/5	Chief Scientific Officer, Director	— mixed-class rows	4,079,565 mixed-class rows	$1,509,439	—	07 Jun 2022	3/4/5
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.76%	196,177	$1,082,897	—	30 Sep 2025	13F
BOOTHBAY FUND MANAGEMENT, LLC	13F	Company	0.69%	178,535	$985,513	—	30 Sep 2025	13F
Matthew R. Kane	3/4/5	President and CEO, Director	— mixed-class rows	2,026,513 mixed-class rows	$749,324	—	07 Jun 2021	3/4/5
ACADIAN ASSET MANAGEMENT LLC	13F	Company	0.46%	119,359	$658,000	—	30 Sep 2025	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.42%	109,521	$604,598	—	30 Sep 2025	13F
BlackRock, Inc.	13F	Company	0.38%	98,699	$544,819	—	30 Sep 2025	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.32%	83,092	$458,668	—	30 Sep 2025	13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC	13F	Company	0.24%	61,901	$341,694	—	30 Sep 2025	13F
Quarry LP	13F	Company	0.23%	59,375	$327,750	—	30 Sep 2025	13F
Tejara Capital Ltd	13F	Company	0.23%	58,752	$324,311	—	30 Sep 2025	13F
COMMONWEALTH EQUITY SERVICES, LLC	13F	Company	0.22%	55,845	$308,000	—	30 Sep 2025	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.2%	52,024	$287,172	—	30 Sep 2025	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.17%	43,641	$240,898	—	30 Sep 2025	13F
Kevin Buehler	3/4/5	Director	— mixed-class rows	49,137 mixed-class rows	$234,961	+$21,116	25 Jun 2025	3/4/5
Melinda Brown	3/4/5	Director	— mixed-class rows	44,346 mixed-class rows	$233,941	+$20,673	15 Dec 2025	3/4/5
Geno J. Germano	3/4/5	Director	— mixed-class rows	44,883 mixed-class rows	$230,639	+$14,160	16 Dec 2025	3/4/5
STATE STREET CORP	13F	Company	0.15%	38,142	$210,544	—	30 Sep 2025	13F
NORTHERN TRUST CORP	13F	Company	0.15%	38,067	$210,130	—	30 Sep 2025	13F
Stanley R. Frankel	3/4/5	Director	— mixed-class rows	40,478 mixed-class rows	$209,458	+$26,109	16 Dec 2025	3/4/5
Shari Lisa Pire	3/4/5	Director	— mixed-class rows	35,028 mixed-class rows	$189,875	—	27 May 2025	3/4/5
Samuel C. Wadsworth	3/4/5	Director	— mixed-class rows	14,028 mixed-class rows	$161,277	—	04 Jun 2024	3/4/5
UBS Group AG	13F	Company	0.09%	24,476	$135,107	—	30 Sep 2025	13F
CITADEL ADVISORS LLC	13F	Company	0.09%	22,142	$122,224	—	30 Sep 2025	13F
Velan Capital Investment Management LP	13F	Company	0.08%	20,000	$110,400	—	30 Sep 2025	13F
GSA CAPITAL PARTNERS LLP	13F	Company	0.07%	17,722	$98,000	—	30 Sep 2025	13F
Virtu Financial LLC	13F	Company	0.06%	15,166	$84,000	—	30 Sep 2025	13F
Quadrature Capital Ltd	13F	Company	0.05%	13,971	$77,120	—	30 Sep 2025	13F
Vanguard Personalized Indexing Management, LLC	13F	Company	0.05%	13,127	$72,461	—	30 Sep 2025	13F
LPL Financial LLC	13F	Company	0.05%	12,041	$66,466	—	30 Sep 2025	13F
MORGAN STANLEY	13F	Company	0.04%	10,474	$57,817	—	30 Sep 2025	13F
Alan List	3/4/5	Chief Medical Officer	— mixed-class rows	5,469 mixed-class rows	$56,440	—	01 May 2024	3/4/5
Corient Private Wealth LLC	13F	Company	0.04%	10,000	$55,200	—	30 Sep 2025	13F
Miller Financial Services LLC	13F	Company	0.04%	10,000	$55,200	—	30 Sep 2025	13F
NATIONAL BANK OF CANADA /FI/	13F	Company	0.03%	7,575	$41,360	—	30 Sep 2025	13F
David S. Thomson	3/4/5	Chief Operating Officer	— mixed-class rows	130,768 mixed-class rows	$41,260	—	23 Jun 2021	3/4/5
Allworth Financial LP	13F	Company	0.02%	4,769	$26,325	—	30 Sep 2025	13F
Vivo Capital, LLC	13F	Company	0.02%	4,675	$25,806	—	30 Sep 2025	13F
Shane Barton	3/4/5	VP & Corporate Controller	— mixed-class rows	33,562 mixed-class rows	$12,418	—	07 Jun 2023	3/4/5
Fayaz Khazi	3/4/5	CEO of Elo Life Systems	— mixed-class rows	65,239 mixed-class rows	$8,880	—	07 Jun 2021	3/4/5

Institutional Holders of PRECISION BIOSCIENCES INC - Common Stock, $0.000005 par value per share (DTIL) as of Q4 2025

As of 31 Dec 2025, PRECISION BIOSCIENCES INC - Common Stock, $0.000005 par value per share (DTIL) was held by 67 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 15,096,207 shares. The largest 10 holders included Empery Asset Management, LP, Aberdeen Group plc, Octagon Capital Advisors LP, Bleichroeder LP, BOOTHBAY FUND MANAGEMENT, LLC, Lynx1 Capital Management LP, VANGUARD GROUP INC, Alyeska Investment Group, L.P., Driehaus Capital Management LLC, and SPHERA FUNDS MANAGEMENT LTD.. This page lists 67 institutional shareholders reporting positions in this security for the Q4 2025 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q4 2025 vs Q3 2025 Across Filers

Q3 2025 holders

Q4 2025 holders

Holder diff

Investor	Q3 2025 Shares	Q4 2025 Shares	Share Diff	Share Chg %	Q3 2025 Value $	Q4 2025 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.